Purchases and Sales Made in Q3 2023 in Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB) during Q3 2023. The information is specifically focused on institutions that hold shares of PharmaCyte Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
K2 Principal Fund, L.P.
Toronto, A6 |
BUY
|
- |
104K+ 67.59% |
$218K - $301K
|
258K
$416K
|
|
|
Nov 14, 2023
Q3 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
97.1KNew |
$203K - $281K
|
97.1K
$156K
|
|
|
Oct 17, 2023
Q3 2023
|
Equitec Proprietary Markets, LLC
|
BUY
|
- |
21.3K+ 34.7% |
$44.5K - $61.6K
|
82.7K
$133K
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
7.03K+ 27.15% |
$14.7K - $20.3K
|
32.9K
$53K
|
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.22KNew |
$2.55K - $3.52K
|
1.22K
$1.96K
|
|
|
Nov 13, 2023
Q3 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
213+ 12.12% |
$445 - $616
|
1.97K
$3.17K
|
|
|
Nov 13, 2023
Q3 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
36+ 0.02% |
$75.2 - $104
|
219K
$353K
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
17New |
$35.5 - $49.1
|
17
$27.4
|
|
|
Nov 13, 2023
Q3 2023
|
Highlander Capital Management, LLC
Short Hills, NJ |
BUY
|
- |
14New |
$29.3 - $40.5
|
14
$22.5
|
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
4+ 0.01% |
$8.36 - $11.6
|
29.3K
$47.2K
|
|
|
Nov 14, 2023
Q3 2023
|
New Edge Advisors, LLC
New Orleans, LA |
BUY
|
- |
1+ 50.0% |
$2.09 - $2.89
|
3
$4.83
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-18- 85.71% |
$37.6 - $52
|
3
$4.83
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-132- 71.35% |
$276 - $381
|
53
$85.3
|
|
|
Nov 14, 2023
Q3 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-200- 0.85% |
$418 - $578
|
23.3K
$37.5K
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.61K- 3.71% |
$3.35K - $4.64K
|
41.7K
$67.2K
|
|
|
Nov 13, 2023
Q3 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-9.13K- 32.14% |
$19.1K - $26.4K
|
19.3K
$31K
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-14.7K- 7.99% |
$30.6K - $42.4K
|
169K
$272K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-29.5K- 45.49% |
$61.7K - $85.3K
|
35.4K
$57K
|
|
|
Nov 01, 2023
Q3 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-47K- 99.58% |
$98.1K - $136K
|
199
$320
|
|
|
Nov 13, 2023
Q3 2023
|
Ayrton Capital LLC
Westport, CT |
SELL
|
- |
-185K- 66.75% |
$386K - $534K
|
92.1K
$148K
|